The NJ Department of Health Recently Announced that the State’s 6 Existing ATCs Can Now Pubicly List Medical Marijuana Prices…
As the medical marijuana industry in New Jersey expands and becomes more competitive, dispensaries will be able to post their prices. The New Jersey Department of Health recently announced that the state’s six existing Alternative Treatment Centers (ATCs) can now publicly list medical marijuana prices on their websites and social media accounts.
“Medical marijuana patients should benefit from online price information just as shoppers do when they buy a car, a plane ticket or any other consumer goods,” Health Commissioner Dr. Shereef Elnahal said in a press statement. “We hope that ATCs take this opportunity to communicate this information to patients. This is part of our ongoing effort to make the Medicinal Marijuana Program more consumer-friendly for patients and caregivers and less restrictive to ATCs.”
The clarification is necessary because the Compassionate Use of Medical Marijuana Act currently restricts advertising. The statute provides that ATCs may not advertise the price of marijuana, with the exception that an ATC can provide a catalog or a printed list of the prices and strains of medicinal marijuana available at the alternative treatment center to registered qualifying patients and primary caregivers.
Under the new guidance, each ATC can decide what, if any, price information to post on their websites. So far, all of the existing dispensaries have taken advantage of the new guidance or have plans to do so.
Expansion of NJ Medical Marijuana Program
The decision to allow ATCs to post their prices reflects the rapid growth of the medical marijuana program under Gov. Phil Murphy. Approximately 33,000 patients are currently enrolled, which is about double the number enrolled in January. Since patients must typically pay for medical cannabis out-of-pocket, cost matters to them. In addition, it will make even more sense to shop around once the number of dispensaries doubles.
As discussed in greater detail in a prior article, the state is moving forward with efforts to add six additional ATCs — two in each of the Northern, Central, and Southern regions of New Jersey. The state’s decision to double the number of dispensaries represents a significant opportunity for businesses seeking to enter New Jersey’s legal marijuana industry, and the response has been overwhelming.
Approvals for New Medical Marijuana Dispensaries Delayed
The New Jersey Department of Health recently notified ATC applicants that it will need additional time to review the 146 applications it received in response to its request to add up to six additional ATCs. The agency had previously stated that it would announce the successful applicants on November 1, 2018.
“Each of the reviewers must read more than 40,000 pages of material (each application averages 300 pages),” the DOH stated. “The reviewers are working as quickly as possible, and the Department will announce the successful applicants as soon as the review is complete.”
The good news is that businesses that are not selected will have a head start the next time around. According to the DOH, it plans to release two additional Requests for Applications in the coming months. The first will be for additional cultivators and manufacturers, and the second for additional dispensary locations.
For entities that are interested in entering the New Jersey cannabis industry, there are numerous legal, logistical and operational issues that must be addressed. Prospective ATC applicants should contact a knowledgeable attorney to discuss this process in greater detail.
If you have any questions, please contact us
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
SEC Takes Actions Against Issuers for Failure to File Form D
In December, the U.S. Securities and Exchange Commission (SEC) announced charges against two privately held companies for failing to file a Form D notice, which is generally utilized for exempt securities offerings. Here, the SEC’s enforcement sends a strong message: compliance with regulatory requirements is not optional and failure to comply can have significant consequences. […]
Redefining Labor Relations: NLRB's Pivot from Abruzzo’s Memoranda
On February 14, 2025, the Office of General Counsel (OGC) of the National Labor Relations Board (NLRB) under Acting General Counsel William B. Cowen issued Memorandum 25-05, “New Process for More Efficient, Effective, Accessible and Transparent Case handling.” The Memorandum rescinds nearly all of the Memoranda issued by his direct predecessor, Jennifer Abruzzo, setting the […]
If you purchase real property from a foreign person or entity, you may be required to withhold taxes from your payment to the seller under the Foreign Investment in Real Property Tax Act (FIRPTA). The federal tax law is designed to ensure that foreign sellers pay any applicable capital gains tax on profits realized from […]
Does Your Homeowners Insurance Provide Adequate Coverage?
Your home is likely your greatest asset, which is why it is so important to adequately protect it. Homeowners insurance protects you from the financial costs of unforeseen losses, such as theft, fire, and natural disasters, by helping you rebuild and replace possessions that were lost While the definition of “adequate” coverage depends upon a […]
Understanding the Importance of a Non-Contingent Offer
Making a non-contingent offer can dramatically increase your chances of securing a real estate transaction, particularly in competitive markets like New York City. However, buyers should understand that waiving contingencies, including those related to financing, or appraisals, also comes with significant risks. Determining your best strategy requires careful analysis of the property, the market, and […]
Fred D. Zemel Appointed Chair of Strategic Planning at Scarinci & Hollenbeck, LLC
Business Transactional Attorney Zemel to Spearhead Strategic Initiatives for Continued Growth and Innovation Little Falls, NJ – February 21, 2025 – Scarinci & Hollenbeck, LLC is pleased to announce that Partner Fred D. Zemel has been named Chair of the firm’s Strategic Planning Committee. In this role, Mr. Zemel will lead the committee in identifying, […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
